Arbutus Biopharma Corporation

NASDAQ:ABUS

Biotechnology

Healthcare
$4.07 +1.13%

+$0.05 today

Market cap
$623.90M
Beta
0.63
P/E (TTM)
5.4
EPS (TTM)
$0.83
52W Low $3.04High $5.10

Volume 2.44M

Average 1.76M

Price history

Arbutus Biopharma Corporation SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-3.10%

Period high

$5.22

Period low

$3.66

Latest

$4.07

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 12, 2026Nov 12, 2026
8-KNov 10, 2026Nov 10, 2026
10-QNov 10, 2026Nov 10, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
8-KOct 22, 2026Oct 22, 2026
SC 13G/AOct 7, 2026Oct 7, 2026
4Oct 7, 2026Oct 7, 2026
4Oct 7, 2026Oct 7, 2026
4Oct 7, 2026Oct 7, 2026
4Oct 7, 2026Oct 7, 2026
SC 13D/AOct 5, 2026Oct 5, 2026
4Oct 5, 2026Oct 5, 2026
SC TO-I/AOct 1, 2026Oct 1, 2026
SC TO-I/ASep 30, 2026Sep 30, 2026
4Sep 23, 2026Sep 23, 2026

Competitors

Who does Arbutus Biopharma Corporation compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ABUS's filings, answered from its disclosures.

What is the latest ABUS filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does ABUS have?

Intrinsic Alpha currently shows 20 recent filings for ABUS.